SCHEMBL14236264

SCHEMBL14236264

Fc1ccc(CNc2ncc(CC3CNc4ncc(Cl)cc43)cn2)cc1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ VNN1 O95497 7/20 0.42
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ NTRK1 P04629 2/20 0.35
▸ SLC6A4 P31645 2/20 0.34
▸ HDAC3 O15379 1/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC2 Q92769 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ MAP2K4 P45985 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ ADORA2A P29274 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ HTR2C P28335 1/20 0.34
▸ HTR2B P41595 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14235596 0.90 NTRK1 (0.33) VNN1NTRK1HDAC3HDAC1HDAC2
SCHEMBL14235722 0.90 HDAC3 (0.47) NTRK1SLC6A4HDAC3HDAC1HDAC2
SCHEMBL14236211 0.89 HDAC1 (0.38) VNN1KDM4EALDH1A1SLC6A4HDAC3
SCHEMBL14236271 0.89 VNN1 (0.41) VNN1ALDH1A1HPGDNTRK1SLC6A4
SCHEMBL14236233 0.89 NTRK1 (0.41) NTRK1
SCHEMBL14235595 0.88 CYP2C9 (0.36) VNN1KDM4ENTRK1HDAC3HDAC1
SCHEMBL12304080 0.86 VNN1 (0.41) VNN1NTRK1SLC6A4HDAC3HDAC1
SCHEMBL14236090 0.85 HDAC3 (0.45) VNN1HDAC3HDAC1HDAC2HDAC6
SCHEMBL14235873 0.85 HDAC3 (0.37) VNN1NTRK1SLC6A4HDAC3HDAC1
SCHEMBL14236274 0.84 VNN1 (0.41) VNN1SLC6A4HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120309756-A1 COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY AND USES THEREFOR PLEXXIKON INC 2012-12-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309756-A1 COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY AND USES THEREFOR KIT, FLT3, FLT1 VNN1 2851/4885KDM4E 2463/4885ALDH1A1 1818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback